Furthermore, through negatively regulating a set of critical genes (e.g., ASB2 and RARA) in AML as RNA m6A demethylase, FTO plays an oncogenic role and inhibits all-trans-retinoic acid (ATRA)-mediated differentiation of leukemia cells [53]. The gene discussed is FTO; the disease is acute myeloid leukemia.